Observational study on hyperthyroidism in children
A Retrospective and Prospective Observational Study of Hyperthyroidism in Children
This study looks at children with hyperthyroidism to see how they are diagnosed, treated, and what their long-term health outcomes are like.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 29 Days to 14 Years |
| Sex | All |
| Sponsor | Shengjing Hospital Academic / other |
| Locations | 1 site (Shenyang, Liaoning) |
| Trial ID | NCT06570967 on ClinicalTrials.gov |
What this trial studies
This study conducts both retrospective and prospective assessments of children diagnosed with hyperthyroidism. It aims to gather information on diagnosis, treatment, and long-term outcomes, focusing on clinical characteristics, treatment effects, side effects, and remission rates. The study will analyze predictive factors for treatment efficacy and the risk of adverse reactions related to antithyroid medications. It is a non-interventional study, meaning no new treatments will be administered; rather, existing data will be utilized.
Who should consider this trial
Good fit: Ideal candidates are children aged 14 years or younger with a confirmed diagnosis of hyperthyroidism.
Not a fit: Patients who have previously received treatment for hyperthyroidism at other hospitals or have certain medical histories may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of hyperthyroidism management in children, leading to improved treatment strategies.
How similar studies have performed: While this study is observational and builds on existing knowledge, similar studies have previously provided valuable insights into pediatric hyperthyroidism management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≤14 years old 2. Initial diagnosis of hyperthyroidism Exclusion Criteria: 1. Hyperthyroidism had been treated with medication in other hospitals, 2. History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation, 3. Patients with incomplete clinical data
Where this trial is running
Shenyang, Liaoning
- Shengjing Hospital of China Medical University — Shenyang, Liaoning, China (Recruiting)
Study contacts
- Study coordinator: Shi Tang, Doctor
- Email: ts047827@163.com
- Phone: +8618940259064
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.